Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

NHS Framework Agreement for the supply of C1-esterase, Icatibant and Conestat Alpha.

  • First published: 29 January 2014
  • Last modified: 29 January 2014

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Commercial Medicines Unit
Authority ID:
AA26502
Publication date:
29 January 2014
Deadline date:
10 March 2014
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS Framework Agreement for the supply of C1-esterase, Icatibant and Conestat Alpha products. The agreement will start on 1.7.2014 to 30.6.2016 with options to extend up to a further 24 months. Please refer to Document No.05d in the ITO documents for the list of Participating Authorities.

Full notice text

CONTRACT NOTICE – OFFICIAL JOURNAL

Section I: Contracting Authority

I.1)

Name, Address and Contact Point(s)


The Secretary of State for Health acting through the Commercial Medicines Unit (part of the Department of Health)

2nd Floor, Rutland House, Cheshire

Runcorn

WA7 2ES

UK

Laura Boyle




https://cmu.bravosolution.co.uk


Checked box
Unchecked box
Checked box
Unchecked box
Checked box
Unchecked box

I.2)

Type of contracting Authority and Main Activity or Activities

Checked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
Public Procurement
Yes

Please refer to the Invitation to Offer

Section II: Object of the Contract

II.1)

Description

II.1.1)

Title attributed to the contract by the contracting authority

NHS Framework Agreement for the supply of C1-esterase, Icatibant and Conestat Alpha.

II.1.2(a))

Type of works contract

II.1.2(b))

Type of supplies contract

Checked box Unchecked box Unchecked box
Unchecked box Unchecked box

II.1.2(c))

Type of service contract

II.1.2)

Main site or location of works, place of delivery or performance

The framework agreement is intended for use by the Department of Health and the NHS in England, Wales and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document No.05d in the ITO documents for the list of Participating Authorities.



II.1.3)

This notice involves

Unchecked box
Unchecked box
Checked box

II.1.4)

Information on framework agreement (if applicable)

Unchecked box
Checked box

Number of participants to the framework agreement envisaged

Duration of the framework agreement

48

Justification for a framework agreement the duration of which exceeds four years

Estimated total value of purchases for the entire duration of the framework agreement

12 979 35015 863 650GBP

Frequency and value of the contracts to be awarded

II.1.5)

Short description of the contract or purchase(s)

NHS Framework Agreement for the supply of C1-esterase, Icatibant and Conestat Alpha products. The agreement will start on 1.7.2014 to 30.6.2016 with options to extend up to a further 24 months. Please refer to Document No.05d in the ITO documents for the list of Participating Authorities.

II.1.6)

Common Procurement Vocabulary (CPV)

33141510
33600000
33141520

II.1.7)

Contract covered by the Government Procurement Agreement (GPA)

Checked box

II.1.8)

Division into lots

Yes

Unchecked box Checked box Unchecked box

II.1.9)

Will variants be accepted

No

II.2)

Quantity or Scope of the Contract

II.2.1)

Total quantity or scope

The contracting authority estimates their requirement over the period of the agreement, including the period of the optional extension, to be approximately 64 954 000 units.

12 979 35015 863 650
GBP

II.2.2)

Options

This framework agreement has the option to be extended for a period of up to a further 24 months

Provisional timetable for recourse to these options

Number of possible renewals

In the case of renewable supplies or service contracts, estimated time frame for subsequent contracts

II.3)

Duration of the contract or limit for completion

 01-07-2014 30-06-2018

Section III: Legal, Economic, Financial and Technical Information

III.1)

Conditions Relating to the Contract

III.1.1)

Deposits and guarantees required

Parent company or other guarantees may be required in certain circumstances

III.1.2)

Main Terms of financing and payment and/or reference to the relevant provisions

Please refer to the Price and Payment clauses contained within the Invitation to Offer, Document No. 03 Conditions of Contract

III.1.3)

Legal form to be taken by the grouping of suppliers, contractors or service providers to whom the contract is to be awarded

No special legal form is required but, if a contract is awarded to a consortium of economic operators, the members of that consortium may be required to form a legal entity before entering into a Framework Agreement and may be required to provide parent company or directors' guarantees or, if not required to form a legal entity, members of a consortium may be required to accept joint and several liability both to the Contracting Authority under the Framework Agreement and to other contracting authorities awarding contracts under the Framework Agreement

III.1.4)

Other particular conditions to which the performance of the contract is subject

Please refer to the Invitation to Offer, Document No. 03, Conditions of Contract

III.2)

Conditions for Participation

III.2.1)

Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers


III.2.2)

Economic and financial capacity


Please refer to the award criteria contained in the Invitation to Offer




III.2.3)

Technical capacity


Please refer to the award criteria contained in the Invitation to Offer




III.2.4)

Reserved contracts

Unchecked box
Unchecked box

Section IV: Procedure

IV.1)

Type of Procedure


Checked box Unchecked box
Unchecked box Unchecked box
Unchecked box Unchecked box

Justification for the choice of accelerated procedure

IV.1.1)

Have candidates already been selected?

No

IV.1.2)

Limitations on the number of operators who will be invited to tender or to participate

Objective criteria for choosing the limited number of candidates

IV.1.3)

Reduction of the number of operators during the negotiation or dialogue

Unchecked box

IV.2)

Award Criteria

No


Yes

No

IV.2.2)

An electronic auction will be used

No

IV.3 Administrative Information

IV.3.1)

Reference number attributed to the notice by the contracting authority

CM/PHS/14/5429

IV.3.2)

Previous publication(s) concerning the same contract

Unchecked box
Unchecked box


Other previous publications

IV.3.3)

Conditions for obtaining specifications and additional documents



 


IV.3.4)

Time-limit for receipt of tenders or requests to participate

 10-03-2014  13:00

IV.3.5)

Date of dispatch of invitations to tender or to participate to selected candidates


IV.3.6)

Language or languages in which tenders or requests to participate can be drawn up

Checked box    

IV.3.7)

Minimum time frame during which the tenderer must maintain the tender 

IV.3.8)

Conditions for opening tenders





Section VI: Other Information

VI.1)

Indicate whether this procurement is a recurrent one and the Estimated timing for further notices to be published


VI.2)

Does the contract relate to a Project/Programme financed by Community Funds?

No



VI.3)

Additional Information

Any supplier may be disqualified who does not respond to the following in the requisite manner:

1) Submission of expression of interest and procurement specific information

This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk. Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:

1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:

— accept the terms and conditions and click continue,

— enter your correct business and user details,

— note the username you chose and click 'Save' when complete,

— you will shortly receive an email with your unique password (please keep this secure).

1.2) Once registered, candidates must express interest as follows:

a. login to the eTendering portal;

b. select 'Response to ITT';

c. select 'ITTs Open To All Suppliers';

d. access listing related to this procurement : C1-esterase, Icatibant and Conestat Alpha and view details;

e. click on 'Express interest' button at the top of the page.

f. Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the 'Publish' button.

1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 8003684850 or help@bravosolution.co.uk

The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.

Contracts awarded under a framework agreement may be awarded either: a) by application of the terms laid down in the framework agreement without reopening competition, or b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.

Potential suppliers should note that, in accordance with the Government's policies on transparency, the Contracting Authority intends to publish the OJEU, ITO and the text of final contracts / framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: https://www.gov.uk/government/policies/buying-and-managing-government-goods-and-services-more-efficiently-and-effectively

VI.4)

Procedures for appeal

VI.4.1)

Body responsible for appeal procedures










Body responsible for mediation procedures










VI.4.2)

Lodging of appeals

VI.4.3)

Service from which information about the lodging of appeals may be obtained










VI.5)

Dispatch date of this Notice

 27-01-2014

ANNEX B

Information About Lots

   

1)

Short Description

Information regarding lots is contained within the Invitation to offer

2)

Common Procurement Vocabulary (CPV)

33141510
33600000
33141520

3)

Quantity or scope


4)

Indication about different contract dates

5)

Additional Information about lots


Coding

Commodity categories

ID Title Parent category
33141510 Blood products Disposable non-chemical medical consumables and haematological consumables
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products
33141520 Plasma extracts Disposable non-chemical medical consumables and haematological consumables

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
N/a
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.